Zachary Ingersoll, DO
Dermatology · Grand Junction, CONPI 1023538956
Payments from drug & device makers
Across 185 payments — averaging $22.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$591
- Sanofi$449
- Sun Pharmaceutical Industries Inc.$441
- Regeneron Healthcare Solutions, Inc.$373
- Lilly USA, LLC$362
- Johnson & Johnson$333
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,56186%
- Education$59214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $591 |
| Sanofi | 16 | $449 |
| Sun Pharmaceutical Industries Inc. | 11 | $441 |
| Regeneron Healthcare Solutions, Inc. | 13 | $373 |
| Lilly USA, LLC | 15 | $362 |
| Johnson & Johnson | 15 | $333 |
| Novartis | 15 | $299 |
| Amgen | 13 | $271 |
| UCB, Inc. | 7 | $159 |
| Incyte Corporation | 7 | $130 |
| Biofrontera Inc. | 7 | $114 |
| E.r. Squibb & Sons, L.L.C. | 3 | $73 |
| Boehringer Ingelheim | 3 | $64 |
| LEO Pharma Inc. | 3 | $61 |
| Pfizer | 3 | $57 |
| Arcutis Biotherapeutics, Inc. | 3 | $50 |
| Galderma Laboratories, L.p. | 3 | $50 |
| Organon | 3 | $45 |
| Dermavant Sciences, Inc. | 2 | $32 |
| Krystal Biotech Inc | 1 | $30 |
| Kerecis Limited | 1 | $26 |
| Biocon Biologics Inc | 1 | $25 |
| Sandoz | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Strata Skin Sciences, Inc. | 2 | $19 |
| Botanix SB Inc | 1 | $18 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $15 |
How this compares
$4,152 in reported general payments places this provider in the 60th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 84 | $328,704 |
| Cyltezo(Cf) PenAdalimumab-Adbm | 17 | $129,700 |
| Humira(Cf) PenAdalimumab | 12 | $96,695 |
| Tacrolimus | 27 | $2,746 |
| Fluorouracil | 42 | $2,745 |
| Clobetasol Propionate | 74 | $2,644 |
| Tretinoin | 23 | $1,980 |
| Doxycycline Hyclate | 68 | $1,481 |
| Mometasone Furoate | 84 | $1,447 |
| Ketoconazole | 84 | $1,301 |
| Triamcinolone Acetonide | 99 | $1,128 |
| Fluconazole | 22 | $579 |
| Clindamycin Phosphate | 14 | $384 |
| Ciclopirox | 14 | $330 |
| ValacyclovirValacyclovir Hcl | 20 | $273 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Grand Junction
- Marcjonathan SerotaLittleton$3.2M
- Stanca BirleaAurora$1.9M
- James SwinehartDenver$931K
- Theodore AlkousakisAurora$880K
- Ammon LarsenLoveland$620K
- Victoria MossColorado Springs$473K
- James JensenCastle Rock$380K
- Cory DunnickAurora$366K
- Kimberly NeymanWheat Ridge$273K
- Sheila BoyleWestminster$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.